Atlas Trials

Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT04014023 · UNKNOWN

Trial details

NCT number
NCT04014023
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
T2DM (Type 2 Diabetes Mellitus)
Start date
2019-07-10
Primary completion
2020-03-01
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.